While there is currently no available cure for <i>NR2E3</i>-related retinopathies, there are a number of emerging therapeutic strategies under investigation, including the use of viral gene therapy and gene editing, that have shown promise for the future treatment of patients with <i>NR2E3</i> variants and other inherited retinal diseases. The gene discussed is NR2E3; the disease is Abnormal retinal morphology.